63 results
424B2
PLSE
Pulse Biosciences Inc
4 Jun 24
Prospectus for primary offering
4:05pm
at what level nor has he made any formal binding commitment to do so.
There is no minimum number of Units that we must sell in order to complete … at what level nor has he made any formal binding commitment to do so.
No Recommendation to Rights Holders
Our board of directors is making
POS AM
PLSE
Pulse Biosciences Inc
28 May 24
Prospectus update (post-effective amendment)
5:19pm
has he made any formal binding commitment to do so.
There is no minimum number of Units that we must sell in order to complete the Rights Offering … he made any formal binding commitment to do so.
No Recommendation to Rights Holders
Our board of directors is making no recommendation regarding your
8-K
EX-99.1
lytvtm7t5dpbnjlql
11 Mar 24
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
9:10am
8-K
EX-99.1
5isvx
14 Feb 24
Other Events
9:22am
8-K
EX-99.1
3ci jf6tk7cr01lc3z
20 Dec 23
Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheter
9:06am
8-K
EX-10.1
q5r8t1ljui45 r5a
1 May 23
Pulse Biosciences Announces $65 Million Private Placement
4:15pm
424B5
joniwm9xmtoy2 jdsi6
4 May 22
Prospectus supplement for primary offering
8:40am